HEMOCATH ​INTELLIGENT HEART FAILURE MONITORING PLATFORM

Transforming Heart Failure Treatment 
by Providing Actionable Clinical Data
for Optimal Medication Dosing and Treatment 
to Reduce Hospitalization and Rehospitalization

​✓   Next generation of pulmonary artery catheters (4F)
✓   Substantially less invasive and easier-to-use
✓   Solution to significant medical needs 
✓   Increased adoption among clinicians
✓   Providing mobility to patients 
✓   Connected to patients’ mobile phone & cloud
✓   Remote patient monitoring (SaaS, AI)
✓   Reducing hospital lenght of stay (LOS)
✓   Providing savings to hospitals

---

​PROBLEMS RESOLVED 

• Current methods to assess heart failure  are LATE and IMPRECISE
• ​Current medical devices to assess heart failure are TOO INVASIVE and RISKY​

​The two most important metrics for the treatment of heart failure are the pulmonary artery pressure (PA) and the central venous pressure (CVP). Unfortunately, these two metrics are not easily available today. So, cardiologists use several indirect methods that are LATE and IMPRECISE. Or, they use medical devices that are TOO INVASIVE and RISKY for most patients. Leading to suboptimal medication dosing, suboptimal treatment, longer hospital stay and rehospitalization.